A
Applied BioCode
Applied biocode designs, develops, and commercializes multiplex testing products
About Applied BioCode
Applied BioCode operates in the biotechnology sector, specializing in digital multiplexing molecular platforms designed for molecular and protein testing. The company's core technology revolves around Barcode Magnetic Beads (BMBs), which are micrometer-scaled and significantly smaller than conventional barcodes. These BMBs are biocompatible and can be used to barcode various biomarkers, enabling comprehensive molecular tests. Applied BioCode serves a diverse range of clients, including clinical laboratories, research institutions, and healthcare providers, offering solutions for molecular diagnostics, gene expression, and biomarker discovery.
Read full description
The company operates primarily in the clinical diagnostics market, providing assays for respiratory pathogens, gastrointestinal pathogens, and other infectious diseases. Applied BioCode's business model is centered on the sale of its proprietary testing platforms and associated consumables, such as assay kits and BMBs. Revenue is generated through the sale of these products and services, as well as through partnerships and collaborations with other entities in the healthcare and life sciences sectors.
Applied BioCode has received FDA 510(k) clearance for its Respiratory Pathogen Panel and Emergency Use Authorization for its SARS-CoV-2 assay, underscoring the reliability and regulatory compliance of its products. The company's offerings are designed to provide high sensitivity and seamless automation for PCR, hybridization, and detection processes, making them suitable for high-volume testing environments.
At a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Santa Fe Springs, United States
- Employees
- 73
- Open positions
- 1
- Dealroom signal
- 49.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Testing, Risk Management, Biotechnology, Gastroenterology, Respiratory, Health Diagnostics
- Technology
- Artificial Intelligence, Deep Tech, Computer Vision
- Business model
- Manufacturing
- Client focus
- b2c
Latest news
Press, funding announcements and product moves mentioning Applied BioCode.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Apr 2016 | $9.3M | $37M | Undisclosed | — |
| EARLY VC✓Equity / VC | Dec 2012 | $1.3M | $5.2M | Undisclosed | — |
Growth signals
Latest recorded traffic for Applied BioCode is 9.2K monthly website visits, up 31.4% over the last three months. Applied BioCode's team grew 5.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors4 additional known investors
GRC SinoGreen Fund- HVHarbinger Ventures
Small Business Innovation Research
Trans Pacific Technology Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Applied BioCode on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Applied BioCode’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.